References
- Mignon C, Sodoyer R, Werle B. Antibiotic-free selection in biotherapeutics: now and forever. Pathogens (Basel, Switzerland) 2015; 4:157-81; PMID:25854922
- Sodoyer R, Courtois V, Peubez I, Mignon C. Antibiotic-free selection for bio-production: moving towards a new “Gold Standard”. In: Dr. Marina Pana (Ed.), ed. Antibiotic Resistant Bacteria - A Continuous Challenge in the New Millennium: InTech, 2012:531-48. Available from: http://www.intechopen.com/books/antibiotic-resistant-bacteria-a-continuous-challenge-in-the-new-millennium/antibiotic-free-selection-for-bio-production-moving-towards-a-new-gold-standard
- Jenkins N, Meleady P, Tyther R, Murphy L. Strategies for analysing and improving the expression and quality of recombinant proteins made in mammalian cells. Biotechnol Appl Biochem 2009; 53:73-83; PMID:19397493; https://doi.org/http://dx.doi.org/10.1042/BA20080258
- Genzel Y. Designing cell lines for viral vaccine production: Where do we stand? Biotechnol J 2015; 10:728-40; PMID:25903999; https://doi.org/http://dx.doi.org/10.1002/biot.201400388
- Li F, Vijayasankaran N, Shen AY, Kiss R, Amanullah A. Cell culture processes for monoclonal antibody production. mAbs 2010; 2:466-79; PMID:20622510; https://doi.org/http://dx.doi.org/10.4161/mabs.2.5.12720
- Michel ML, Pontisso P, Sobczak E, Malpiece Y, Streeck RE, Tiollais P. Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc Natl Acad Sci U S A 1984; 81:7708-12.
- Jungers P, Chauveau P, Courouce AM, Devillier P, Excler JL, Bailleux F, Saliou P. Immunogenicity of the recombinant GenHevac B Pasteur vaccine against hepatitis B in chronic uremic patients. J Infect Dis 1994; 169:399-402; PMID:8106774; https://doi.org/http://dx.doi.org/10.1093/infdis/169.2.399
- Tron F, Degos F, Brechot C, Courouce AM, Goudeau A, Marie FN, Adamowicz P, Saliou P, Laplanche A, Benhamou JP, et al. Randomized dose range study of a recombinant hepatitis B vaccine produced in mammalian cells and containing the S and PreS2 sequences. J Infect Dis 1989; 160:199-204; PMID:2527274; https://doi.org/http://dx.doi.org/10.1093/infdis/160.2.199
- Zhang C, Buchanan H, Andrews W, Evans A, Pass RF. Detection of cytomegalovirus infection during a vaccine clinical trial in healthy young women: seroconversion and viral shedding. J Clin Virol: Off Pub Pan Am Soc Clin Virol 2006; 35:338-42; PMID:16388984; https://doi.org/http://dx.doi.org/10.1016/j.jcv.2005.09.020
- McVoy MA. Cytomegalovirus vaccines. Clin Infect Dis: Off Pub Infect Dis Soc Am 2013; 57 Suppl 4:S196-9; PMID:24257427; https://doi.org/http://dx.doi.org/10.1093/cid/cit587
- Hofmann I, Wen Y, Ciferri C, Schulze A, Fuhner V, Leong M, Gerber A, Gerrein R, Nandi A, Lilja AE, et al. Expression of the human cytomegalovirus pentamer complex for vaccine use in a CHO system. Biotechnol Bioeng 2015; 112:2505-15; PMID:26058896; https://doi.org/http://dx.doi.org/10.1002/bit.25670
- Daramola O, Stevenson J, Dean G, Hatton D, Pettman G, Holmes W, Field R. A high-yielding CHO transient system: coexpression of genes encoding EBNA-1 and GS enhances transient protein expression. Biotechnol Prog 2014; 30:132-41; PMID:24106171; https://doi.org/http://dx.doi.org/10.1002/btpr.1809
- Abbott WM, Middleton B, Kartberg F, Claesson J, Roth R, Fisher D. Optimisation of a simple method to transiently transfect a CHO cell line in high-throughput and at large scale. Prot Exp Purificat 2015; 116:113-9; PMID:26291269; https://doi.org/http://dx.doi.org/10.1016/j.pep.2015.08.016
- Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36:59-74; PMID:886304; https://doi.org/http://dx.doi.org/10.1099/0022-1317-36-1-59
- Stepanenko AA, Dmitrenko VV. HEK293 in cell biology and cancer research: phenotype, karyotype, tumorigenicity, and stress-induced genome-phenotype evolution. Gene 2015; 569:182-90; PMID:26026906; https://doi.org/http://dx.doi.org/10.1016/j.gene.2015.05.065
- Bussow K. Stable mammalian producer cell lines for structural biology. Curr Opin Struct Biol 2015; 32:81-90; PMID:25804355; https://doi.org/http://dx.doi.org/10.1016/j.sbi.2015.03.002
- Fontana D, Kratje R, Etcheverrigaray M, Prieto C. Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate. Vaccine 2015; 33:4238-46; PMID:25869890; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2015.03.088
- Lin J, Li X, Yuan F, Lin L, Cook CL, Rao Ch V, Lei Z. Genetic ablation of luteinizing hormone receptor improves the amyloid pathology in a mouse model of Alzheimer disease. J Neuropathol Exp Neurol 2010; 69:253-61; PMID:20142765; https://doi.org/http://dx.doi.org/10.1097/NEN.0b013e3181d072cf
- Cachianes G, Ho C, Weber RF, Williams SR, Goeddel DV, Leung DW. Epstein-Barr virus-derived vectors for transient and stable expression of recombinant proteins. BioTechniques 1993; 15:255-9; PMID:8396947
- DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 1987; 7:379-87; PMID:3031469; https://doi.org/http://dx.doi.org/10.1128/MCB.7.1.379
- Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 1982; 298:347-50; PMID:7045698; https://doi.org/http://dx.doi.org/10.1038/298347a0
- Walsh G. Biopharmaceutical benchmarks 2014. Nat Biotechnol 2014; 32:992-1000; PMID:25299917; https://doi.org/http://dx.doi.org/10.1038/nbt.3040
- Moreira ED, Jr., Block SL, Ferris D, Giuliano AR, Iversen OE, Joura EA, Kosalaraksa P, Schilling A, Van Damme P, Bornstein J, et al. Safety profile of the 9-valent HPV vaccine: a combined analysis of 7 phase III clinical trials. Pediatrics 2016; 138.
- Cereghino JL, Cregg JM. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev 2000; 24:45-66; PMID:10640598; https://doi.org/http://dx.doi.org/10.1111/j.1574-6976.2000.tb00532.x
- Daly R, Hearn MT. Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production. J Mol Recognit: JMR 2005; 18:119-38; PMID:15565717; https://doi.org/http://dx.doi.org/10.1002/jmr.687
- Gasser B, Prielhofer R, Marx H, Maurer M, Nocon J, Steiger M, Puxbaum V, Sauer M, Mattanovich D. Pichia pastoris: protein production host and model organism for biomedical research. Fut Microbiol 2013; 8:191-208; PMID:23374125; https://doi.org/http://dx.doi.org/10.2217/fmb.12.133
- Macauley-Patrick S, Fazenda ML, McNeil B, Harvey LM. Heterologous protein production using the Pichia pastoris expression system. Yeast (Chichester, England) 2005; 22:249-70; PMID:15704221; https://doi.org/http://dx.doi.org/10.1002/yea.1208
- Ahmad M, Hirz M, Pichler H, Schwab H. Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production. App Microbiol Biotechnol 2014; 98:5301-17; PMID:24743983; https://doi.org/http://dx.doi.org/10.1007/s00253-014-5732-5
- Looser V, Bruhlmann B, Bumbak F, Stenger C, Costa M, Camattari A, Fotiadis D, Kovar K. Cultivation strategies to enhance productivity of Pichia pastoris: A review. Biotechnol Adv 2015; 33:1177-93; PMID:26027890; https://doi.org/http://dx.doi.org/10.1016/j.biotechadv.2015.05.008
- Bill RM. Recombinant protein subunit vaccine synthesis in microbes: a role for yeast? J Pharm Pharmacol 2015; 67:319-28; PMID:25556638; https://doi.org/http://dx.doi.org/10.1111/jphp.12353
- Curti E, Kwityn C, Zhan B, Gillespie P, Brelsford J, Deumic V, Plieskatt J, Rezende WC, Tsao E, Kalampanayil B, et al. Expression at a 20L scale and purification of the extracellular domain of the Schistosoma mansoni TSP-2 recombinant protein: a vaccine candidate for human intestinal schistosomiasis. Human vaccines & immunotherapeutics 2013; 9:2342-50; PMID:23899507; https://doi.org/http://dx.doi.org/10.4161/hv.25787
- Mani S, Tripathi L, Raut R, Tyagi P, Arora U, Barman T, Sood R, Galav A, Wahala W, de Silva A, et al. Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies. PloS One 2013; 8:e64595; PMID:23717637; https://doi.org/http://dx.doi.org/10.1371/journal.pone.0064595
- Gurramkonda C, Zahid M, Nemani SK, Adnan A, Gudi SK, Khanna N, Ebensen T, Lunsdorf H, Guzman CA, Rinas U. Purification of hepatitis B surface antigen virus-like particles from recombinant Pichia pastoris and in vivo analysis of their immunogenic properties. J Chromatograp B, Anal Technol Biomed Life Sci 2013; 940:104-11; PMID:24141044; https://doi.org/http://dx.doi.org/10.1016/j.jchromb.2013.09.030
- Jha R, Lakhtakia S, Jaleel MA, Narayan G, Hemlatha K. Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders. Renal Fail 2001; 23:629-36; PMID:11725909; https://doi.org/http://dx.doi.org/10.1081/JDI-100107359
- Hamilton SR, Bobrowicz P, Bobrowicz B, Davidson RC, Li H, Mitchell T, Nett JH, Rausch S, Stadheim TA, Wischnewski H, et al. Production of complex human glycoproteins in yeast. Science (New York, NY) 2003; 301:1244-6; https://doi.org/http://dx.doi.org/10.1126/science.1088166
- Beck A, Cochet O, Wurch T. GlycoFi's technology to control the glycosylation of recombinant therapeutic proteins. Exp Opin Drug Disc 2010; 5:95-111; PMID:22823974; https://doi.org/http://dx.doi.org/10.1517/17460440903413504
- Vervecken W, Callewaert N, Kaigorodov V, Geysens S, Contreras R. Modification of the N-glycosylation pathway to produce homogeneous, human-like glycans using GlycoSwitch plasmids. Methods Mol Biol (Clifton, NJ) 2007; 389:119-38; https://doi.org/http://dx.doi.org/10.1007/978-1-59745-456-8_9
- Jacobs PP, Geysens S, Vervecken W, Contreras R, Callewaert N. Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology. Nat Protocols 2009; 4:58-70; PMID:19131957; https://doi.org/http://dx.doi.org/10.1038/nprot.2008.213
- Smith ET, Perry ET, Sears MB, Johnson DA. Expression of recombinant human mast cell chymase with Asn-linked glycans in glycoengineered Pichia pastoris. Prot Expr Purificat 2014; 102:69-75; PMID:25131858; https://doi.org/http://dx.doi.org/10.1016/j.pep.2014.08.005
- Madzak C. Yarrowia lipolytica: recent achievements in heterologous protein expression and pathway engineering. Appl Microbiol Biotechnol 2015; 99:4559-77; PMID:25947247; https://doi.org/http://dx.doi.org/10.1007/s00253-015-6624-z
- Wartmann T, Boer E, Pico AH, Sieber H, Bartelsen O, Gellissen G, Kunze G. High-level production and secretion of recombinant proteins by the dimorphic yeast Arxula adeninivorans. FEMS Yeast Res 2002; 2:363-9; PMID:12702286
- Wartmann T, Kruger A, Adler K, Duc BM, Kunze I, Kunze G. Temperature-dependent dimorphism of the yeast Arxula adeninivorans Ls3. Antonie van Leeuwenhoek 1995; 68:215-23; PMID:8572679; https://doi.org/http://dx.doi.org/10.1007/BF00871818
- Yang XX, Wartmann T, Stoltenburg R, Kunze G. Halotolerance of the yeast Arxula adeninivorans LS3. Antonie van Leeuwenhoek 2000; 77:303-11; PMID:10959559; https://doi.org/http://dx.doi.org/10.1023/A:1002636606282
- van Ooyen AJ, Dekker P, Huang M, Olsthoorn MM, Jacobs DI, Colussi PA, Taron CH. Heterologous protein production in the yeast Kluyveromyces lactis. FEMS Yeast Res 2006; 6:381-92; PMID:16630278; https://doi.org/http://dx.doi.org/10.1111/j.1567-1364.2006.00049.x
- Fleer R, Chen XJ, Amellal N, Yeh P, Fournier A, Guinet F, Gault N, Faucher D, Folliard F, Fukuhara H, et al. High-level secretion of correctly processed recombinant human interleukin-1 beta in Kluyveromyces lactis. Gene 1991; 107:285-95; PMID:1748298; https://doi.org/http://dx.doi.org/10.1016/0378-1119(91)90329-A
- Hua Z, Liang X, Zhu D. Expression and purification of a truncated macrophage colony stimulating factor in Kluyveromyces lactis. Biochem Mol Biol Int 1994; 34:419-27; PMID:7849653
- Swennen D, Paul MF, Vernis L, Beckerich JM, Fournier A, Gaillardin C. Secretion of active anti-Ras single-chain Fv antibody by the yeasts Yarrowia lipolytica and Kluyveromyces lactis. Microbiol (Reading, England) 2002; 148:41-50; PMID:11782497; https://doi.org/http://dx.doi.org/10.1099/00221287-148-1-41
- Robin S, Petrov K, Dintinger T, Kujumdzieva A, Tellier C, Dion M. Comparison of three microbial hosts for the expression of an active catalytic scFv. Mol Immunol 2003; 39:729-38; PMID:12531284; https://doi.org/http://dx.doi.org/10.1016/S0161-5890(02)00253-5
- Habersetzer F, Baumert TF, Stoll-Keller F. GI-5005, a yeast vector vaccine expressing an NS3-core fusion protein for chronic HCV infection. Curr Opin Mol Therap 2009; 11:456-62; PMID:19649991
- Upadhyaya B, Manjunath R. Baker's yeast expressing the Japanese encephalitis virus envelope protein on its cell surface: induction of an antigen-specific but non-neutralizing antibody response. Yeast (Chichester, England) 2009; 26:383-97; PMID:19504623; https://doi.org/http://dx.doi.org/10.1002/yea.1676
- Shibasaki S, Aoki W, Nomura T, Miyoshi A, Tafuku S, Sewaki T, Ueda M. An oral vaccine against candidiasis generated by a yeast molecular display system. Path Disease 2013; 69:262-8; PMID:23873745; https://doi.org/http://dx.doi.org/10.1111/2049-632X.12068
- Shin MK, Yoo HS. Animal vaccines based on orally presented yeast recombinants. Vaccine 2013; 31:4287-92; PMID:23891501; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2013.07.029
- Arnold M, Durairaj V, Mundt E, Schulze K, Breunig KD, Behrens SE. Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit. PloS One 2012; 7:e42870; PMID:23024743; https://doi.org/http://dx.doi.org/10.1371/journal.pone.0042870
- Mahalik S, Sharma AK, Mukherjee KJ. Genome engineering for improved recombinant protein expression in Escherichia coli. Microb Cell Fact 2014; 13:177; PMID:25523647; https://doi.org/http://dx.doi.org/10.1186/s12934-014-0177-1
- Retallack DM, Jin H, Chew L. Reliable protein production in a Pseudomonas fluorescens expression system. Prot Exp Purificat 2012; 81:157-65; PMID:21968453; https://doi.org/http://dx.doi.org/10.1016/j.pep.2011.09.010
- Gruber S, Schwab H, Koefinger P. Versatile plasmid-based expression systems for Gram-negative bacteria-General essentials exemplified with the bacterium Ralstonia eutropha H16. New Biotechnol 2015; 32:552-8; PMID:25865178; https://doi.org/http://dx.doi.org/10.1016/j.nbt.2015.03.015
- Habibi N, Mohd Hashim SZ, Norouzi A, Samian MR. A review of machine learning methods to predict the solubility of overexpressed recombinant proteins in Escherichia coli. BMC Bioinform 2014; 15:134; PMID:24885721; https://doi.org/http://dx.doi.org/10.1186/1471-2105-15-134
- Wacker M, Linton D, Hitchen PG, Nita-Lazar M, Haslam SM, North SJ, Panico M, Morris HR, Dell A, Wren BW, et al. N-linked glycosylation in Campylobacter jejuni and its functional transfer into E.coli. Science (New York, NY) 2002; 298:1790-3; https://doi.org/http://dx.doi.org/10.1126/science.298.5599.1790
- Jaffe SR, Strutton B, Levarski Z, Pandhal J, Wright PC. Escherichia coli as a glycoprotein production host: recent developments and challenges. Curr Opin Biotechnol 2014; 30:205-10; PMID:25156401; https://doi.org/http://dx.doi.org/10.1016/j.copbio.2014.07.006
- Song Y, Nikoloff JM, Zhang D. Improving protein production on the level of regulation of both expression and secretion pathways in bacillus subtilis. J Microbiol Biotechnol 2015; 25:963-77; PMID:25737123; https://doi.org/http://dx.doi.org/10.4014/jmb.1501.01028
- Wyszynska A, Kobierecka P, Bardowski J, Jagusztyn-Krynicka EK. Lactic acid bacteria-20 years exploring their potential as live vectors for mucosal vaccination. Appl Microbiol Biotechnol 2015; 99:2967-77; PMID:25750046; https://doi.org/http://dx.doi.org/10.1007/s00253-015-6498-0
- Palmiter RD, Brinster RL, Hammer RE, Trumbauer ME, Rosenfeld MG, Birnberg NC, Evans RM. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 1982; 300:611-5; PMID:6958982; https://doi.org/http://dx.doi.org/10.1038/300611a0
- Bosch P, Forcato DO, Alustiza FE, Alessio AP, Fili AE, Olmos Nicotra MF, Liaudat AC, Rodriguez N, Talluri TR, Kues WA. Exogenous enzymes upgrade transgenesis and genetic engineering of farm animals. Cell Mol Life Sci 2015; 72:1907-29; PMID:25636347; https://doi.org/http://dx.doi.org/10.1007/s00018-015-1842-1
- Ousterout DG, Gersbach CA. The Development of TALE Nucleases for Biotechnology. Methods Mol Biol (Clifton, NJ) 2016; 1338:27-42; https://doi.org/http://dx.doi.org/10.1007/978-1-4939-2932-0_3
- Redel BK, Prather RS. Meganucleases revolutionize the production of genetically engineered Pigs for the study of human diseases. Toxicol Pathol 2015; PMID:26516165
- Konkle BA, Bauer KA, Weinstein R, Greist A, Holmes HE, Bonfiglio J. Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures. Transfusion 2003; 43:390-4; PMID:12675726; https://doi.org/http://dx.doi.org/10.1046/j.1537-2995.2003.00315.x
- Wang Y, Zhao S, Bai L, Fan J, Liu E. Expression systems and species used for transgenic animal bioreactors. Biomed Res Int 2013; 2013:580463; PMID:23586046
- Cao D, Wu H, Li Q, Sun Y, Liu T, Fei J, Zhao Y, Wu S, Hu X, Li N. Expression of recombinant human lysozyme in egg whites of transgenic hens. PloS One 2015; 10:e0118626; PMID:25706123; https://doi.org/http://dx.doi.org/10.1371/journal.pone.0118626
- Adachi K, Takama K, Tsukamoto M, Inai M, Handharyani E, Hiroi S, Tsukamoto Y. Ostrich produce cross-reactive neutralization antibodies against pandemic influenza virus A/H1N1 following immunization with a seasonal influenza vaccine. Exp Ther Med 2011; 2:41-5; PMID:22977467
- Soukharev S, Hammond D, Ananyeva NM, Anderson JA, Hauser CA, Pipe S, Saenko EL. Expression of factor VIII in recombinant and transgenic systems. Blood Cells Mol Dis 2002; 28:234-48; PMID:12064919; https://doi.org/http://dx.doi.org/10.1006/bcmd.2002.0508
- Echelard Y, Williams JL, Destrempes MM, Koster JA, Overton SA, Pollock DP, Rapiejko KT, Behboodi E, Masiello NC, Gavin WG, et al. Production of recombinant albumin by a herd of cloned transgenic cattle. Transgenic Res 2009; 18:361-76; PMID:19031005; https://doi.org/http://dx.doi.org/10.1007/s11248-008-9229-9
- Tavares KC, Dias AC, Lazzarotto CR, Gaudencio Neto S, de Sa Carneiro I, Ongaratto FL, Pinto AF, de Aguiar LH, Calderon CE, Toledo JR, et al. Transient expression of functional glucocerebrosidase for treatment of gaucher's disease in the goat mammary gland. Mol Biotechnol 2016; 58:47-55.
- Behboodi E, Ayres SL, Memili E, O'Coin M, Chen LH, Reggio BC, Landry AM, Gavin WG, Meade HM, Godke RA, et al. Health and reproductive profiles of malaria antigen-producing transgenic goats derived by somatic cell nuclear transfer. Cloning Stem Cells 2005; 7:107-18; PMID:15971984; https://doi.org/http://dx.doi.org/10.1089/clo.2005.7.107
- Vazquez-Salat N, Salter B, Smets G, Houdebine LM. The current state of GMO governance: are we ready for GM animals? Biotechnol Adv 2012; 30:1336-43; PMID:22361646; https://doi.org/http://dx.doi.org/10.1016/j.biotechadv.2012.02.006
- Vazquez-Salat N, Houdebine LM. Will GM animals follow the GM plant fate? Transgenic Res 2013; 22:5-13; PMID:22987246; https://doi.org/http://dx.doi.org/10.1007/s11248-012-9648-5
- Harrap KA, Tinsley TW. A suggested latinized nomenclature of occluded insect viruses. J Invertebrate Pathol 1971; 17:294-6; PMID:5575751; https://doi.org/http://dx.doi.org/10.1016/0022-2011(71)90111-X
- Smith GE, Summers MD, Fraser MJ. Production of human beta interferon in insect cells infected with a baculovirus expression vector. Mol Cell Biol 1983; 3:2156-65; PMID:6318086; https://doi.org/http://dx.doi.org/10.1128/MCB.3.12.2156
- Zhao Y, Chapman DA, Jones IM. Improving baculovirus recombination. Nucleic Acids Res 2003; 31:E6-; PMID:12527795; https://doi.org/http://dx.doi.org/10.1093/nar/gng006
- Hitchman RB, Possee RD, King LA. High-throughput baculovirus expression in insect cells. Methods Mol Biol (Clifton, NJ) 2012; 824:609-27.
- Cox MM. Recombinant protein vaccines produced in insect cells. Vaccine 2012; 30:1759-66; PMID:22265860; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2012.01.016
- Maeda S, Kawai T, Obinata M, Fujiwara H, Horiuchi T, Saeki Y, Sato Y, Furusawa M. Production of human alpha-interferon in silkworm using a baculovirus vector. Nature 1985; 315:592-4; PMID:2989694; https://doi.org/http://dx.doi.org/10.1038/315592a0
- Kato T, Kajikawa M, Maenaka K, Park EY. Silkworm expression system as a platform technology in life science. Appl Microbiol Biotechnol 2010; 85:459-70; PMID:19830419; https://doi.org/http://dx.doi.org/10.1007/s00253-009-2267-2
- Jin R, Lv Z, Chen Q, Quan Y, Zhang H, Li S, Chen G, Zheng Q, Jin L, Wu X, et al. Safety and immunogenicity of H5N1 influenza vaccine based on baculovirus surface display system of Bombyx mori. PloS One 2008; 3:e3933; PMID:19079592; https://doi.org/http://dx.doi.org/10.1371/journal.pone.0003933
- Li Z, Yi Y, Yin X, Zhang Z, Liu J. Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine. PloS One 2008; 3:e2273; PMID:18509464; https://doi.org/http://dx.doi.org/10.1371/journal.pone.0002273
- Fernandes F, Dias MM, Vidigal J, Sousa MF, Patrone M, Teixeira AP, Alves PM. Production of rotavirus core-like particles in Sf9 cells using recombinase-mediated cassette exchange. J Biotechnol 2014; 171:34-8; PMID:24333128; https://doi.org/http://dx.doi.org/10.1016/j.jbiotec.2013.11.020
- Govindarajan D, Meschino S, Guan L, Clements DE, ter Meulen JH, Casimiro DR, Coller BA, Bett AJ. Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates. Vaccine 2015; 33:4105-16; PMID:26144900; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2015.06.067
- Jarvi SI, Hu D, Misajon K, Coller BA, Wong T, Lieberman MM. Vaccination of captive nene (Branta sandvicensis) against West Nile virus using a protein-based vaccine (WN-80E). J Wildl Dis 2013; 49:152-6; PMID:23307381; https://doi.org/http://dx.doi.org/10.7589/2011-12-363
- Nielsen MA, Resende M, de Jongh WA, Ditlev SB, Mordmuller B, Houard S, Ndam NT, Agerbaek MO, Hamborg M, Massougbodji A, et al. The influence of sub-unit composition and expression system on the functional antibody response in the development of a VAR2CSA based plasmodium falciparum placental malaria vaccine. PloS One 2015; 10:e0135406; PMID:26327283; https://doi.org/http://dx.doi.org/10.1371/journal.pone.0135406
- Takeyama N, Kiyono H, Yuki Y. Plant-based vaccines for animals and humans: recent advances in technology and clinical trials. Ther Adv Vaccines 2015; 3:139-54; PMID:26668752; https://doi.org/http://dx.doi.org/10.1177/2051013615613272
- De Leede LG, Humphries JE, Bechet AC, Van Hoogdalem EJ, Verrijk R, Spencer DG. Novel controlled-release Lemna-derived IFN-alpha2b (Locteron): pharmacokinetics, pharmacodynamics, and tolerability in a phase I clinical trial. J Interferon Cytokine Res 2008; 28:113-22; PMID:18279106; https://doi.org/http://dx.doi.org/10.1089/jir.2007.0073
- Zhang D, Lee HF, Pettit SC, Zaro JL, Huang N, Shen WC. Characterization of transferrin receptor-mediated endocytosis and cellular iron delivery of recombinant human serum transferrin from rice (Oryza sativa L.). BMC Biotechnol 2012; 12:92; PMID:23194296; https://doi.org/http://dx.doi.org/10.1186/1472-6750-12-92
- Shen JS, Busch A, Day TS, Meng XL, Yu CI, Dabrowska-Schlepp P, Fode B, Niederkruger H, Forni S, Chen S, et al. Mannose receptor-mediated delivery of moss-made alpha-galactosidase A efficiently corrects enzyme deficiency in Fabry mice. J Inherit Metab Dis 2016; 39:293-303; PMID:26310963
- Hefferon K. Plant virus expression vector development: new perspectives. Biomed Res Int 2014; 2014:785382; PMID:24745025; https://doi.org/http://dx.doi.org/10.1155/2014/785382
- Landry N, Ward BJ, Trepanier S, Montomoli E, Dargis M, Lapini G, Vezina LP. Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PloS One 2010; 5:e15559; PMID:21203523; https://doi.org/http://dx.doi.org/10.1371/journal.pone.0015559
- Olinger GG, Jr., Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc Natl Acad Sci U S A 2012; 109:18030-5.
- Martinez MJ, Salim AM, Hurtado JC, Kilgore PE. Ebola Virus Infection: Overview and Update on Prevention and Treatment. Infect Dis Ther 2015; 4:365-90; PMID:26363787; https://doi.org/http://dx.doi.org/10.1007/s40121-015-0079-5
- Shaaltiel Y, Bartfeld D, Hashmueli S, Baum G, Brill-Almon E, Galili G, Dym O, Boldin-Adamsky SA, Silman I, Sussman JL, et al. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system. Plant Biotechnol J 2007; 5:579-90; PMID:17524049; https://doi.org/http://dx.doi.org/10.1111/j.1467-7652.2007.00263.x
- Ratner M. Pfizer stakes a claim in plant cell-made biopharmaceuticals. Nat Biotechnol 2010; 28:107-8; PMID:20139928; https://doi.org/http://dx.doi.org/10.1038/nbt0210-107
- Qin S, Lin H, Jiang P. Advances in genetic engineering of marine algae. Biotechnol Adv 2012; 30:1602-13; PMID:22634258; https://doi.org/http://dx.doi.org/10.1016/j.biotechadv.2012.05.004
- Potvin G, Zhang Z. Strategies for high-level recombinant protein expression in transgenic microalgae: a review. Biotechnol Adv 2010; 28:910-8; PMID:20728531; https://doi.org/http://dx.doi.org/10.1016/j.biotechadv.2010.08.006
- Rasala BA, Mayfield SP. Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses. Photosynth Res 2015; 123:227-39; PMID:24659086; https://doi.org/http://dx.doi.org/10.1007/s11120-014-9994-7
- Sun M, Qian K, Su N, Chang H, Liu J, Shen G. Foot-and-mouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast. Biotechnol Lett 2003; 25:1087-92; PMID:12889819; https://doi.org/http://dx.doi.org/10.1023/A:1024140114505
- He DM, Qian KX, Shen GF, Zhang ZF, Li YN, Su ZL, Shao HB. Recombination and expression of classical swine fever virus (CSFV) structural protein E2 gene in Chlamydomonas reinhardtii chroloplasts. Colloids Surf B, Biointerfaces 2007; 55:26-30; PMID:17188850; https://doi.org/http://dx.doi.org/10.1016/j.colsurfb.2006.10.042
- Akbari F, Eskandani M, Khosroushahi AY. The potential of transgenic green microalgae; a robust photobioreactor to produce recombinant therapeutic proteins. World J Microbiol Biotechnol 2014; 30:2783-96; PMID:25115849; https://doi.org/http://dx.doi.org/10.1007/s11274-014-1714-0
- Surzycki R, Greenham K, Kitayama K, Dibal F, Wagner R, Rochaix JD, Ajam T, Surzycki S. Factors effecting expression of vaccines in microalgae. Biologicals: J Int Assoc Biol Standardizat 2009; 37:133-8; PMID:19467445; https://doi.org/http://dx.doi.org/10.1016/j.biologicals.2009.02.005
- Feng S, Feng W, Zhao L, Gu H, Li Q, Shi K, Guo S, Zhang N. Preparation of transgenic Dunaliella salina for immunization against white spot syndrome virus in crayfish. Arch Virol 2014; 159:519-25; PMID:24081826; https://doi.org/http://dx.doi.org/10.1007/s00705-013-1856-7
- Rosales-Mendoza S. Future directions for the development of Chlamydomonas-based vaccines. Exp Rev Vacc 2013; 12:1011-9; PMID:24053395; https://doi.org/http://dx.doi.org/10.1586/14760584.2013.825455
- Dauvillee D, Delhaye S, Gruyer S, Slomianny C, Moretz SE, d'Hulst C, Long CA, Ball SG, Tomavo S. Engineering the chloroplast targeted malarial vaccine antigens in Chlamydomonas starch granules. PloS One 2010; 5:e15424; PMID:21179538; https://doi.org/http://dx.doi.org/10.1371/journal.pone.0015424
- Gregory JA, Li F, Tomosada LM, Cox CJ, Topol AB, Vinetz JM, Mayfield S. Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission. PloS One 2012; 7:e37179; PMID:22615931; https://doi.org/http://dx.doi.org/10.1371/journal.pone.0037179
- Patra KP, Li F, Carter D, Gregory JA, Baga S, Reed SG, Mayfield SP, Vinetz JM. Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes. Infect Immun 2015; 83:1799-808; PMID:25690099; https://doi.org/http://dx.doi.org/10.1128/IAI.02980-14
- Franklin SE, Mayfield SP. Recent developments in the production of human therapeutic proteins in eukaryotic algae. Exp Opin Biolog Ther 2005; 5:225-35; PMID:15757384; https://doi.org/http://dx.doi.org/10.1517/14712598.5.2.225
- Franklin SE, Mayfield SP. Prospects for molecular farming in the green alga Chlamydomonas. Curr Opin Plant Biol 2004; 7:159-65; PMID:15003216; https://doi.org/http://dx.doi.org/10.1016/j.pbi.2004.01.012
- Perkins FO. The ultrastructure of holdfasts, “rhizoids”, and “slime tracks” in Thraustochytriaceous fungi and Labyrinthula spp. Archiv fur Mikrobiologie 1972; 84:95-118; PMID:4559400; https://doi.org/http://dx.doi.org/10.1007/BF00412431
- Ratledge C. Fatty acid biosynthesis in microorganisms being used for Single Cell Oil production. Biochimie 2004; 86:807-15; PMID:15589690; https://doi.org/http://dx.doi.org/10.1016/j.biochi.2004.09.017
- Lippmeier JC, Crawford KS, Owen CB, Rivas AA, Metz JG, Apt KE. Characterization of both polyunsaturated fatty acid biosynthetic pathways in Schizochytrium sp. Lipids 2009; 44:621-30; PMID:19495823; https://doi.org/http://dx.doi.org/10.1007/s11745-009-3311-9
- Bayne AC, Boltz D, Owen C, Betz Y, Maia G, Azadi P, Archer-Hartmann S, Zirkle R, Lippmeier JC. Vaccination against influenza with recombinant hemagglutinin expressed by Schizochytrium sp. confers protective immunity. PloS One 2013; 8:e61790; https://doi.org/http://dx.doi.org/10.1371/journal.pone.0061790
- Specht EA, Mayfield SP. Algae-based oral recombinant vaccines. Front Microbiol 2014; 5:60; PMID:24596570; https://doi.org/http://dx.doi.org/10.3389/fmicb.2014.00060
- Dreesen IA, Charpin-El Hamri G, Fussenegger M. Heat-stable oral alga-based vaccine protects mice from Staphylococcus aureus infection. J Biotechnol 2010; 145:273-80; PMID:19995584; https://doi.org/http://dx.doi.org/10.1016/j.jbiotec.2009.12.006
- Zaug AJ, Cech TR. The intervening sequence RNA of Tetrahymena is an enzyme. Science (New York, NY) 1986; 231:470-5; https://doi.org/http://dx.doi.org/10.1126/science.3941911
- Orgel LE. RNA catalysis and the origins of life. J Theor Biol 1986; 123:127-49; PMID:2442564; https://doi.org/http://dx.doi.org/10.1016/S0022-5193(86)80149-7
- Weide T, Herrmann L, Bockau U, Niebur N, Aldag I, Laroy W, Contreras R, Tiedtke A, Hartmann MW. Secretion of functional human enzymes by Tetrahymena thermophila. BMC Biotechnol 2006; 6:19; PMID:16542419; https://doi.org/http://dx.doi.org/10.1186/1472-6750-6-19
- Cowan GJ, Bockau U, Eleni-Muus J, Aldag I, Samuel K, Creasey AM, Hartmann MW, Cavanagh DR. A novel malaria vaccine candidate antigen expressed in Tetrahymena thermophila. PloS One 2014; 9:e87198; PMID:24489871; https://doi.org/http://dx.doi.org/10.1371/journal.pone.0087198
- Peterson DS, Gao Y, Asokan K, Gaertig J. The circumsporozoite protein of Plasmodium falciparum is expressed and localized to the cell surface in the free-living ciliate Tetrahymena thermophila. Mol Biochem Parasitol 2002; 122:119-26; PMID:12106865; https://doi.org/http://dx.doi.org/10.1016/S0166-6851(02)00079-8
- Yilmaz G, Arslanyolu M. Efficient expression of codon-adapted affinity tagged super folder green fluorescent protein for synchronous protein localization and affinity purification studies in Tetrahymena thermophila. BMC Biotechnol 2015; 15:22; PMID:25887423; https://doi.org/http://dx.doi.org/10.1186/s12896-015-0137-9
- Bisharyan Y, Clark TG. Calcium-dependent mitochondrial extrusion in ciliated protozoa. Mitochondrion 2011; 11:909-18; PMID:21856451; https://doi.org/http://dx.doi.org/10.1016/j.mito.2011.08.001
- Basile G, Peticca M. Recombinant protein expression in Leishmania tarentolae. Mol Biotechnol 2009; 43:273-8; PMID:19779853; https://doi.org/http://dx.doi.org/10.1007/s12033-009-9213-5
- Fritsche C, Sitz M, Weiland N, Breitling R, Pohl HD. Characterization of the growth behavior of Leishmania tarentolae: a new expression system for recombinant proteins. J Basic Microbiol 2007; 47:384-93; PMID:17910102; https://doi.org/http://dx.doi.org/10.1002/jobm.200710111
- Breitling R, Klingner S, Callewaert N, Pietrucha R, Geyer A, Ehrlich G, Hartung R, Muller A, Contreras R, Beverley SM, et al. Non-pathogenic trypanosomatid protozoa as a platform for protein research and production. Prot Exp Purificat 2002; 25:209-18; PMID:12135552; https://doi.org/http://dx.doi.org/10.1016/S1046-5928(02)00001-3
- Kushnir S, Gase K, Breitling R, Alexandrov K. Development of an inducible protein expression system based on the protozoan host Leishmania tarentolae. Prot Exp Purificat 2005; 42:37-46; PMID:15939291; https://doi.org/http://dx.doi.org/10.1016/j.pep.2005.03.004
- Kushnir S, Cirstea IC, Basiliya L, Lupilova N, Breitling R, Alexandrov K. Artificial linear episome-based protein expression system for protozoon Leishmania tarentolae. Mol Biochem Parasitol 2011; 176:69-79; PMID:21167214; https://doi.org/http://dx.doi.org/10.1016/j.molbiopara.2010.12.002
- Mirzaahmadi S, Asaadi-Tehrani G, Bandehpour M, Davoudi N, Tahmasbi L, Hosseinzadeh N, Mirzahoseini H, Parivar K, Kazemi B. Expression of recombinant human coagulation factor VII by the Lizard Leishmania expression system. J Biomed Biotechnol 2011; 2011:873874; PMID:21912483; https://doi.org/http://dx.doi.org/10.1155/2011/873874
- Klatt S, Hartl D, Fauler B, Gagoski D, Castro-Obregon S, Konthur Z. Generation and characterization of a Leishmania tarentolae strain for site-directed in vivo biotinylation of recombinant proteins. J Proteome Res 2013; 12:5512-9; PMID:24093329; https://doi.org/http://dx.doi.org/10.1021/pr400406c
- Baechlein C, Meemken D, Pezzoni G, Engemann C, Grummer B. Expression of a truncated hepatitis E virus capsid protein in the protozoan organism Leishmania tarentolae and its application in a serological assay. J Virolog Methods 2013; 193:238-43; PMID:23747546; https://doi.org/http://dx.doi.org/10.1016/j.jviromet.2013.05.018
- Jones JD. Leishmania tarentolae: an alternative approach to the production of monoclonal antibodies to treat emerging viral infections. Infect Dis Poverty 2015; 4:8; PMID:26191408; https://doi.org/http://dx.doi.org/10.1186/2049-9957-4-8
- Pion C, Courtois V, Husson S, Bernard MC, Nicolai MC, Talaga P, Trannoy E, Moste C, Sodoyer R, Legastelois I. Characterization and immunogenicity in mice of recombinant influenza haemagglutinins produced in Leishmania tarentolae. Vaccine 2014; 32:5570-6; PMID:25131728; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2014.07.092
- Punt PJ, Levasseur A, Visser H, Wery J, Record E. Fungal protein production: design and production of chimeric proteins. Ann Rev Microbiol 2011; 65:57-69; PMID:21639784; https://doi.org/http://dx.doi.org/10.1146/annurev.micro.112408.134009
- Lubertozzi D, Keasling JD. Developing Aspergillus as a host for heterologous expression. Biotechnol Adv 2009; 27:53-75; PMID:18840517; https://doi.org/http://dx.doi.org/10.1016/j.biotechadv.2008.09.001
- MacRae WD, Buxton FP, Gwynne DI, Davies RW. Heterologous protein secretion directed by a repressible acid phosphatase system of Aspergillus niger. Gene 1993; 132:193-8; PMID:8224863; https://doi.org/http://dx.doi.org/10.1016/0378-1119(93)90195-9
- Broekhuijsen MP, Mattern IE, Contreras R, Kinghorn JR, van den Hondel CA. Secretion of heterologous proteins by Aspergillus niger: production of active human interleukin-6 in a protease-deficient mutant by KEX2-like processing of a glucoamylase-hIL6 fusion protein. J Biotechnol 1993; 31:135-45; PMID:7764298; https://doi.org/http://dx.doi.org/10.1016/0168-1656(93)90156-H
- Gasser B, Mattanovich D. Antibody production with yeasts and filamentous fungi: on the road to large scale? Biotechnol Lett 2007; 29:201-12; PMID:17120087; https://doi.org/http://dx.doi.org/10.1007/s10529-006-9237-x
- Moghadamtousi SZ, Nikzad S, Kadir HA, Abubakar S, Zandi K. Potential antiviral agents from marine fungi: an overview. Marine Drugs 2015; 13:4520-38; PMID:26204947; https://doi.org/http://dx.doi.org/10.3390/md13074520
- Keranen S, Penttila M. Production of recombinant proteins in the filamentous fungus Trichoderma reesei. Curr Opin Biotechnol 1995; 6:534-7; PMID:7579664; https://doi.org/http://dx.doi.org/10.1016/0958-1669(95)80088-3
- Peterson R, Nevalainen H. Trichoderma reesei RUT-C30-thirty years of strain improvement. Microbiol (Reading, England) 2012; 158:58-68; PMID:21998163; https://doi.org/http://dx.doi.org/10.1099/mic.0.054031-0
- Xu J, Li J, Lin L, Liu Q, Sun W, Huang B, Tian C. Development of genetic tools for Myceliophthora thermophila. BMC Biotechnol 2015; 15:35; PMID:26013561; https://doi.org/http://dx.doi.org/10.1186/s12896-015-0165-5
- Zamecnik PC, Frantz ID, Jr., et al. Incorporation in vitro of radioactive carbon from carboxyl-labeled dl-alanine and glycine into proteins of normal and malignant rat livers. J Biol Chem 1948; 175:299-314; PMID:18873305
- Chong S. Overview of cell-free protein synthesis: historic landmarks, commercial systems, and expanding applications. Curr Protoc Mol Biol 2014; 108:16.30.1-16.30.11.
- Bank A, Marks PA. Protein synthesis in a cell free human reticulocyte system: ribosome function in thalassemia. J Clin Invest 1966; 45:330-6; PMID:5904550; https://doi.org/http://dx.doi.org/10.1172/JCI105347
- Gale EF, Folkes JP. Effect of nucleic acids on protein synthesis and amino-acid incorporation in disrupted staphylococcal cells. Nature 1954; 173:1223-7; PMID:13176417; https://doi.org/http://dx.doi.org/10.1038/1731223a0
- Lamborg MR, Zamecnik PC. Amino acid incorporation into protein by extracts of E. coli. Biochim Biophys Acta 1960; 42:206-11; https://doi.org/http://dx.doi.org/10.1016/0006-3002(60)90782-4
- Gan R, Jewett MC. A combined cell-free transcription-translation system from Saccharomyces cerevisiae for rapid and robust protein synthe. Biotechnol J 2014; 9:641-51; PMID:24677809; https://doi.org/http://dx.doi.org/10.1002/biot.201300545
- Wang X, Liu J, Zheng Y, Li J, Wang H, Zhou Y, Qi M, Yu H, Tang W, Zhao WM. An optimized yeast cell-free system: sufficient for translation of human papillomavirus 58 L1 mRNA and assembly of virus-like particles. J Biosci Bioeng 2008; 106:8-15; PMID:18691524; https://doi.org/http://dx.doi.org/10.1263/jbb.106.8
- Buntru M, Vogel S, Spiegel H, Schillberg S. Tobacco BY-2 cell-free lysate: an alternative and highly-productive plant-based in vitro translation system. BMC Biotechnol 2014; 14:37; PMID:24886601; https://doi.org/http://dx.doi.org/10.1186/1472-6750-14-37
- Merk H, Stiege W, Tsumoto K, Kumagai I, Erdmann VA. Cell-free expression of two single-chain monoclonal antibodies against lysozyme: effect of domain arrangement on the expression. J Biochem 1999; 125:328-33; PMID:9990130; https://doi.org/http://dx.doi.org/10.1093/oxfordjournals.jbchem.a022290
- Merk H, Rues RB, Gless C, Beyer K, Dong F, Dotsch V, Gerrits M, Bernhard F. Biosynthesis of membrane dependent proteins in insect cell lysates: identification of limiting parameters for folding and processing. Biol Chem 2015; 396:1097-107; PMID:25999328; https://doi.org/http://dx.doi.org/10.1515/hsz-2015-0105
- Yadavalli R, Sam-Yellowe T. HeLa based cell free expression systems for expression of plasmodium rhoptry proteins. J Vis Exp 2015:e52772; PMID:26131624
- Volyanik EV, Dalley A, McKay IA, Leigh I, Williams NS, Bustin SA. Synthesis of preparative amounts of biologically active interleukin-6 using a continuous-flow cell-free translation system. Anal Biochem 1993; 214:289-94; PMID:8250237; https://doi.org/http://dx.doi.org/10.1006/abio.1993.1490
- Shirokov VA, Kommer A, Kolb VA, Spirin AS. Continuous-exchange protein-synthesizing systems. Methods Mol Biol (Clifton, NJ) 2007; 375:19-55.
- Matsuda T, Watanabe S, Kigawa T. Cell-free synthesis system suitable for disulfide-containing proteins. Biochem Biophys Res Commun 2013; 431:296-301; PMID:23291178; https://doi.org/http://dx.doi.org/10.1016/j.bbrc.2012.12.107
- Zichel R, Mimran A, Keren A, Barnea A, Steinberger-Levy I, Marcus D, Turgeman A, Reuveny S. Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system. Clin Vaccine Immunol 2010; 17:784-92; PMID:20357058; https://doi.org/http://dx.doi.org/10.1128/CVI.00496-09
- Shimizu Y, Kuruma Y, Kanamori T, Ueda T. The PURE system for protein production. Methods Mol Biol (Clifton, NJ) 2014; 1118:275-84; https://doi.org/http://dx.doi.org/10.1007/978-1-62703-782-2_19
- Li J, Gu L, Aach J, Church GM. Improved cell-free RNA and protein synthesis system. PloS One 2014; 9:e106232; PMID:25180701; https://doi.org/http://dx.doi.org/10.1371/journal.pone.0106232
- Takai K, Sawasaki T, Endo Y. Practical cell-free protein synthesis system using purified wheat embryos. Nat Protocols 2010; 5:227-38; PMID:20134421; https://doi.org/http://dx.doi.org/10.1038/nprot.2009.207
- Yin G, Garces ED, Yang J, Zhang J, Tran C, Steiner AR, Roos C, Bajad S, Hudak S, Penta K, et al. Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system. mAbs 2012; 4:217-25; PMID:22377750; https://doi.org/http://dx.doi.org/10.4161/mabs.4.2.19202
- Groff D, Armstrong S, Rivers PJ, Zhang J, Yang J, Green E, Rozzelle J, Liang S, Kittle JD, Jr., Steiner AR, et al. Engineering toward a bacterial “endoplasmic reticulum” for the rapid expression of immunoglobulin proteins. mAbs 2014; 6:671-8; PMID:24517929; https://doi.org/http://dx.doi.org/10.4161/mabs.28172
- Cai Q, Hanson JA, Steiner AR, Tran C, Masikat MR, Chen R, Zawada JF, Sato AK, Hallam TJ, Yin G. A simplified and robust protocol for immunoglobulin expression in Escherichia coli cell-free protein synthesis systems. Biotechnol Prog 2015; 31:823-31; PMID:25826247; https://doi.org/http://dx.doi.org/10.1002/btpr.2082
- Sullivan CJ, Pendleton ED, Sasmor HH, Hicks WL, Farnum JB, Muto M, Amendt EM, Schoborg JA, Martin RW, Clark LG, et al. A cell-free expression and purification process for rapid production of protein biologics. Biotechnol J 2015; PMID:26427345
- Zaheer R, Klima CL, McAllister TA. Expeditious screening of candidate proteins for microbial vaccines. J Microbiol Methods 2015; 116:53-9; PMID:26149626; https://doi.org/http://dx.doi.org/10.1016/j.mimet.2015.06.018
- Aguiar JC, Bolton J, Wanga J, Sacci JB, Iriko H, Mazeika JK, Han ET, Limbach K, Patterson NB, Sedegah M, et al. Discovery of novel plasmodium falciparum pre-erythrocytic antigens for vaccine development. PloS One 2015; 10:e0136109; PMID:26292257; https://doi.org/http://dx.doi.org/10.1371/journal.pone.0136109
- Ozawa K, Loh CT. Site-specific incorporation of unnatural amino acids into proteins by cell-free protein synthesis. Methods Mol Biol (Clifton, NJ) 2014; 1118:189-203; https://doi.org/http://dx.doi.org/10.1007/978-1-62703-782-2_12
- Liu CC, Schultz PG. Adding new chemistries to the genetic code. Annu Rev Biochem 2010; 79:413-44; PMID:20307192; https://doi.org/http://dx.doi.org/10.1146/annurev.biochem.052308.105824
- Hong SH, Kwon YC, Jewett MC. Non-standard amino acid incorporation into proteins using Escherichia coli cell-free protein synthesis. Front Chem 2014; 2:34; PMID:24959531; https://doi.org/http://dx.doi.org/10.3389/fchem.2014.00034
- Casteleijn MG, Urtti A, Sarkhel S. Expression without boundaries: cell-free protein synthesis in pharmaceutical research. Int J Pharm 2013; 440:39-47; PMID:22521712; https://doi.org/http://dx.doi.org/10.1016/j.ijpharm.2012.04.005
- Zeng W, Eriksson EM, Lew A, Jackson DC. Lipidation of intact proteins produces highly immunogenic vaccine candidates. Mol Immunol 2011; 48:490-6; PMID:21056473; https://doi.org/http://dx.doi.org/10.1016/j.molimm.2010.10.003